Literature DB >> 8106835

Effect of acylation on the ocular disposition of acyclovir. I: Synthesis, physicochemical properties, and antiviral activity of 2'-esters.

P M Hughes1, R Krishnamoorthy, A K Mitra.   

Abstract

A series of aliphatic 2'-esters of acyclovir ([9-(2-hydroxyethoxymethyl)guanine]) were synthesized by direct acylation in a pyridine-N,N-dimethylformamide solution. The prodrugs were characterized as to their aqueous solubility in phosphate buffer (pH 7.4), partition coefficients in 1-octanol/phosphate buffer (pH 7.4), bioreversion kinetics by the soluble ocular esterases, and in vitro effectiveness against Herpes group viruses. The compounds exhibit an expected decrease in aqueous solubility upon esterification with a corresponding increase in the 1-octanol/water partition coefficient. The butyrate ester shows good aqueous stability in the neutral pH ranges. The apparent first order rate constants of bioreversion varied with the steric nature and polarity of the acyl substituent. The butyrate and pivalate esters were evaluated for their anti-herpesvirus activity and cellular toxicity. The butyrate ester possesses similar anti-herpesvirus activity to acyclovir and has a very high selectivity index. The pivalate ester shows poor anti-herpes simplex virus activity; however, it is unique in its effectiveness against the Epstein-Barr virus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106835     DOI: 10.1089/jop.1993.9.287

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  6 in total

Review 1.  Novel strategies for anterior segment ocular drug delivery.

Authors:  Kishore Cholkar; Sulabh P Patel; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-05       Impact factor: 2.671

2.  Vitreal pharmacokinetics of biotinylated ganciclovir: role of sodium-dependent multivitamin transporter expressed on retina.

Authors:  Kumar G Janoria; Sai H S Boddu; Zhiying Wang; Durga K Paturi; Swapan Samanta; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2009-02       Impact factor: 2.671

3.  Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea.

Authors:  Banmeet S Anand; Ashim K Mitra
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

4.  Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.

Authors:  Suresh Katragadda; Sriram Gunda; Sudharshan Hariharan; Ashim K Mitra
Journal:  Int J Pharm       Date:  2008-03-22       Impact factor: 5.875

5.  Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux.

Authors:  Pradeep K Karla; Tim L Quinn; Betty L Herndon; Priscilla Thomas; Dhananjay Pal; Ashim Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2009-04       Impact factor: 2.671

6.  Small Neutral Amino Acid Ester Prodrugs of Acyclovir Targeting Amino Acid Transporters on the Cornea: Possible Antiviral Agents Against Ocular HSV-1 Infections.

Authors:  Katragadda Suresh; Zhu Xiadong; Talluri S Ravi; Ashim K Mitra
Journal:  Ophthalmol Eye Dis       Date:  2010-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.